Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 868 posts found.

Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
Stephen Whitehead image

Stephen Whitehead: pharma has transformed

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

Feature
Soliris image

NICE approves world’s most expensive drug

January 28, 2015
Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris

The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …

News
Xarelto image

NICE recommends Bayer heart attack drug

January 26, 2015
Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …

News
J&J image

Olysio and Xarelto boost J&J’s Q4

January 21, 2015
Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four

Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …

News

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

News
Olysio image

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015
Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

News
Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

News

NICE releases reflux disease guidelines

January 15, 2015
Sales and Marketing NHS, NICE, UK, gor, gord, h2ra

NICE has released new guidelines providing doctors with advice on how to treat gastro-oesophageal reflux disease (GORD) in young people. …

News
dendreon image

Another NICE no for Dendreon cancer drug

January 13, 2015
Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T

Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …

News
AZ image

AstraZeneca drops CDF application

January 12, 2015
Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib

AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …

News
Sativex image

Late-stage failure for Otsuka and GW cancer pain drug

January 9, 2015
Sales and Marketing Cancer, Epidiolex, GW, MS, NICE, Otsuka, Sativex, cannabidiol, nabiximols

Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary endpoint in its first Phase III …

News
Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

News
Entyvio image

NICE rejects Takeda Crohn’s disease drug

December 23, 2014
Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …

News
Janssen image

Janssen launches HIV combination pill

December 17, 2014
Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …

News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026